CannapharmaRx to Complete Additional Shipment in November
CannaPharmaRx (OTC PINK:CPMD) reports continued progress at its Cremona, Alberta facility with uninterrupted cannabis cultivation despite CEO Dean Medwid's resignation in September. The company has completed two shipments to Israel and is preparing a third shipment of approximately 300 kg at CAD 2.10 per gram. An additional 250 kg order for Israel is scheduled for delivery this quarter. CannaPharmaRx expects regular orders and shipments throughout 2025, projecting significant revenue growth. The company is also in preliminary discussions with European companies to expand its international distribution network.
CannaPharmaRx (OTC PINK:CPMD) riporta progressi continui presso la sua struttura di Cremona, Alberta, con una coltivazione di cannabis ininterrotta nonostante le dimissioni del CEO Dean Medwid a settembre. L'azienda ha completato due spedizioni verso Israele e sta preparando una terza spedizione di circa 300 kg a 2,10 CAD per grammo. Un ulteriore ordine di 250 kg per Israele è programmato per la consegna in questo trimestre. CannaPharmaRx si aspetta ordini e spedizioni regolari per tutto il 2025, prevedendo una crescita significativa dei ricavi. L'azienda è anche in discussioni preliminari con aziende europee per espandere la propria rete di distribuzione internazionale.
CannaPharmaRx (OTC PINK:CPMD) informa sobre un progreso continuo en su instalación de Cremona, Alberta, con un cultivo de cannabis ininterrumpido a pesar de la renuncia del CEO Dean Medwid en septiembre. La empresa ha completado dos envíos a Israel y se está preparando para un tercer envío de aproximadamente 300 kg a 2,10 CAD por gramo. Un pedido adicional de 250 kg para Israel está programado para entrega en este trimestre. CannaPharmaRx espera realizar pedidos y envíos regulares a lo largo de 2025, proyectando un crecimiento significativo en los ingresos. La empresa también está en discusiones preliminares con empresas europeas para expandir su red de distribución internacional.
CannaPharmaRx (OTC PINK:CPMD)는 CEO인 딘 메드윗의 9월 사임에도 불구하고 알버타주 크레모나 시설에서 지속적으로 대마초 재배를 진행하고 있다고 보고했습니다. 이 회사는 이스라엘에 두 번의 배송을 완료했으며 약 300kg의 세 번째 배송을 위해 준비 중이며, 가격은 g당 2.10 CAD입니다. 이 분기에 이스라엘에 대한 추가 250kg 주문이 예정되어 있습니다. CannaPharmaRx는 2025년 내내 정기적인 주문과 배송이 이루어질 것으로 기대하고 있으며, 상당한 수익 성장도 예상하고 있습니다. 이 회사는 또한 국제 유통 네트워크를 확장하기 위해 유럽 기업들과 초기 논의를 진행하고 있습니다.
CannaPharmaRx (OTC PINK:CPMD) fait état de progrès continus dans son installation de Cremona, Alberta, avec une culture de cannabis ininterrompue en dépit de la démission du PDG Dean Medwid en septembre. L'entreprise a complété deux expéditions vers Israël et prépare une troisième expédition d'environ 300 kg au prix de 2,10 CAD par gramme. Une commande supplémentaire de 250 kg pour Israël est prévue pour une livraison ce trimestre. CannaPharmaRx s'attend à des commandes et des expéditions régulières tout au long de 2025, prévoyant une croissance significative des revenus. L'entreprise est également en discussions préliminaires avec des sociétés européennes pour élargir son réseau de distribution international.
CannaPharmaRx (OTC PINK:CPMD) berichtet von fortwährendem Fortschritt in seiner Anlage in Cremona, Alberta, mit ununterbrochener Cannabisproduktion trotz des Rücktritts von CEO Dean Medwid im September. Das Unternehmen hat zwei Lieferungen nach Israel abgeschlossen und bereitet eine dritte Lieferung von etwa 300 kg zu 2,10 CAD pro Gramm vor. Eine zusätzliche Bestellung von 250 kg für Israel ist für die Lieferung in diesem Quartal geplant. CannaPharmaRx erwartet regelmäßige Bestellungen und Lieferungen bis 2025 und prognostiziert ein signifikantes Umsatzwachstum. Das Unternehmen führt zudem erste Gespräche mit europäischen Firmen, um sein internationales Vertriebsnetz zu erweitern.
- Successfully completed two shipments to Israel
- Secured new order for 250 kg shipment to Israel
- Third shipment of 300 kg in preparation at CAD 2.10 per gram
- Operations continued uninterrupted despite CEO resignation
- Expanding international market presence through discussions with European companies
- Recent CEO resignation indicates management instability
CALGARY, AB / ACCESSWIRE / November 5, 2024 / CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cutting-edge, highly efficient cannabis production, is pleased to announce continued progress at its Cremona, Alberta facility, where cannabis cultivation remains on track according to the company's annual plan. Following the resignation of CEO Dean Medwid in early September, the company has been able to maintain uninterrupted operations while fulfilling and delivering its orders.
Recent Shipments to Israel
CannaPharmaRx has completed two shipments of its products to purchasers in Israel. A third shipment of approximately 300 kg is currently in the final stages of preparation and is expected to be dispatched in the near term. The average price for the third shipment is projected at CAD 2.10 per gram, with final pricing based on batch quality and THC results.
Additionally, an order for a shipment of 250 kg of company product to Israel has been received and is scheduled for delivery during the current quarter.
The company anticipates a regular cadence of orders and shipments during 2025 resulting in significant revenue growth next year.
Following the successful launch of the company's products in Israel, CannaPharmaRx is in preliminary discussions with companies in Europe and elsewhere internationally to increase the distribution of our products and to establish a global presence.
Contact:
Company: CannapharmaRx
Name: Constanitne Nkafu
Website: https://cannapharmarx.com
Phone: 403-637-0420
Mail: info@cannapharmarx.com
SOURCE: CannaPharmaRx
View the original press release on accesswire.com
FAQ
What is the size and price of CannaPharmaRx's (CPMD) upcoming third shipment to Israel?
How many shipments has CannaPharmaRx (CPMD) completed to Israel in 2024?
What are CannaPharmaRx's (CPMD) international expansion plans for 2025?
